Financials
Financial year 2025
Revenue
€ 43.2 million
▼ 6% vs 2024
Profit
Growing€ 2.8 million
▲ 4% vs 2024
Debts
Low€ 14.9 million
▼ 23% vs 2024
Purna Pharmaceuticals from Puurs-Sint-Amands, company number BE0428742176, closed financial year 2025 with a result of € 2.8 million after tax. For that financial year Purna Pharmaceuticals recorded revenue of € 43.2 million and equity of € 19.4 million. Compared with financial year 2024, the result moved from € 2.7 million to € 2.8 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 5, 2026.
What happened at Purna Pharmaceuticals?
What happened at Purna Pharmaceuticals in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- David J. Parker stepped down as director. NBB
- Hidde Van Kerckhoven stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 2.8 million (▲ 4% vs 2024). Source: NBB ↗
- David J. Parker became a director. NBB
- BART M.J. PEETERS BV stepped down as director. NBB
- Hidde Van Kerckhoven became a director. NBB
- LEA SMETS stepped down as director. NBB
- CREAFUND ASSET MANAGEMENT NV stepped down as director. NBB
In short
From € 575,564 loss in 2021 to € 2.8 million profit in 2025.
Paid € 131,338 in corporate taxes since 2021.
Best year ever: 2025, with € 2.8 million profit.
Pays suppliers within 59 days on average.
A new publication or filing at Purna Pharmaceuticals? We notify you, reason included.
Follow Purna PharmaceuticalsNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Directors
According to the 2025 annual accounts
Managing director · represented by BART PEETERS
since 2021 · until 2026
David J. Parker
Director
since 2026 · until 2032
Hidde Van Kerckhoven
Director
since 2026 · until 2032
LEA SMETS
Director
since 2021 · until 2026
Director · represented by RUTH DE WULF
since 2021 · until 2026
RAYMOND VAN GUCHT
Chairman of the board
since 2021 · until 2026
Establishments
Establishment units
Physical locations of this company
Rijksweg 17
2870 Puurs-Sint-Amands
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
Website
Technologies
Hosting & Email
Email provider
Barracuda
Hosting
COMBELL-AS, BE
Website info
Features
Security
Network
Details
- Company number
- 0428.742.176
- VAT number
- BE 0428.742.176
- Registered office
- Rijksweg 17, 2870 Puurs-Sint-Amands
- Names & denominations
- Purna Pharmaceuticals
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 4 April 1986
- Peppol
- Active · Active since 1 Jan 2001
- Contact
- purna.be
- Activities · NACE
Vervaardiging van geneesmiddelen
Vervaardiging van overige farmaceutische producten
Vervaardiging van overige farmaceutische preparaten
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten